SHENZHEN, China, June 30, 2020 /PRNewswire/ -- Today Immvira Group Company (Immvira or the "Company"), a biotechnology company focused on the development of new generation oncolytic viruses as potential cancer therapeutics, announces the appointment of Carl Yeung as Chief Financial...
from PR Newswire: https://ift.tt/2NLUMXU
No comments:
Post a Comment